No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal, Murine-Derived / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cladribine / administration & dosage
-
Drug Resistance, Neoplasm
-
Flow Cytometry
-
Glutamic Acid
-
Humans
-
Indoles / administration & dosage
-
Indoles / adverse effects
-
Indoles / pharmacology*
-
Indoles / therapeutic use*
-
Induction Chemotherapy
-
Leukemia, Hairy Cell / diagnosis
-
Leukemia, Hairy Cell / drug therapy*
-
Leukemia, Hairy Cell / genetics*
-
Male
-
Middle Aged
-
Molecular Targeted Therapy
-
Point Mutation*
-
Proto-Oncogene Proteins B-raf / antagonists & inhibitors*
-
Proto-Oncogene Proteins B-raf / genetics
-
Rituximab
-
Sulfonamides / administration & dosage
-
Sulfonamides / adverse effects
-
Sulfonamides / pharmacology*
-
Sulfonamides / therapeutic use*
-
Treatment Outcome
-
Valine
-
Vemurafenib
Substances
-
Antibodies, Monoclonal, Murine-Derived
-
Indoles
-
Sulfonamides
-
Vemurafenib
-
Glutamic Acid
-
Cladribine
-
Rituximab
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf
-
Valine